RBOT

Vicarious Surgical Inc. is a robotics company, developing technology to improve surgical procedures. The Company is combining advanced miniaturized robotics, computer science, sensing and three-dimensional (3D) visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.8 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.

Wall Street analysts forecast RBOT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RBOT is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Vicarious Surgical Inc revenue for the last quarter amounts to -11.50M USD, decreased -35.21 % YoY.

Vicarious Surgical Inc. EPS for the last quarter amounts to -10581000.00 USD, decreased -16.61 % YoY.

Vicarious Surgical Inc (RBOT) has 123 emplpoyees as of December 15 2025.

Today RBOT has the market capitalization of 17.36M USD.